News Releases
Monday, November 29, 2021
First-in-Human Study of Golodirsen for Duchenne Muscular DystrophyTuesday, August 11, 2020
First in Human Study with Novel Antisense OligonucleotideWednesday, November 13, 2019
New Method Described for Quantifying Antisense Oligonucleotides in NucleiThursday, April 4, 2019
New Guidelines Push for Better Controlled Experiments with Synthetic Nucleic AcidsThursday, February 7, 2019
Anti-microRNAs are Possible New Therapeutic Target for Type 2 DiabetesMonday, January 28, 2019
Targeted Antisense Oligonucleotide Drug Tested in HumansFriday, March 30, 2018
Rational Protein Engineering Can Improve Effectiveness of mRNA TherapiesTuesday, January 9, 2018
New Method Stabilizes siRNAs Without Affecting Gene Silencing ActivitySociety Affiliations
The Official Journal of: